Research programme: ion channel modulators - SWITCH Biotech

Drug Profile

Research programme: ion channel modulators - SWITCH Biotech

Alternative Names: Psoriasis therapies research programme - SWITCH Biotech; SWT 01.103; SWT 01.1xx; SWT 01.2xx; SWT 01103

Latest Information Update: 02 Jun 2005

Price : $50

At a glance

  • Originator SWITCH Biotech (CEASED)
  • Class
  • Mechanism of Action Ion channel modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Psoriasis

Most Recent Events

  • 01 Mar 2005 Discontinued - Preclinical for Psoriasis in Germany (unspecified route)
  • 01 Mar 2005 SWITCH Biotech has closed down
  • 30 Jan 2003 Preclinical trials in Psoriasis in Germany (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top